A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice

As SARS-CoV-2 continues to cause morbidity and mortality around the world, there is an urgent need for the development of effective medical countermeasures. Here, we assessed the antiviral capacity of a minimal RIG-I agonist, stem-loop RNA 14 (SLR14), in viral control, disease prevention, post-infec...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:bioRxiv
Prif Awduron: Mao, Tianyang, Israelow, Benjamin, Lucas, Carolina, Vogels, Chantal B. F., Fedorova, Olga, Breban, Mallery I., Menasche, Bridget L., Dong, Huiping, Linehan, Melissa, Wilen, Craig B., Landry, Marie L., Grubaugh, Nathan D., Pyle, Anna M., Iwasaki, Akiko
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Cold Spring Harbor Laboratory 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8219094/
https://ncbi.nlm.nih.gov/pubmed/34159330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.06.16.448754
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg